1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for 'CFS'.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 28th April 2025 is here.
    Dismiss Notice
  3. Welcome! Read the Core Purpose and Values of our forum.
    Dismiss Notice

'Conditions related to ME/CFS' news and research

Post and discuss news and research related to conditions potentially related to ME/CFS' including IBS, POTS, fibromyalgia, post-treatment lyme disease, Gulf War Illness.

Page 12 of 45
Sort By:
Title Start Date
Replies Views
Last Message ↓
  1. chillier

    Excitable dynamics of flares and relapses in autoimmune diseases 2023 Lebel et al

    chillier, Dec 26, 2023
    Replies:
    6
    Views:
    1,074
    Jonathan Edwards
    Jan 21, 2024
  2. Andy

    Repeated cold stress, an animal model for [FM], elicits proprioceptor-induced chronic pain with microglial activation in mice 2024 Wakatsuki et al

    Andy, Jan 20, 2024
    Replies:
    1
    Views:
    705
    MeSci
    Jan 20, 2024
  3. Jaybee00

    Trial Report Naltrexone 6 mg once daily versus placebo in women with fibromyalgia: a randomised, double-blind, placebo-controlled trialBruun 2023

    Jaybee00, Dec 8, 2023
    Replies:
    13
    Views:
    1,682
    dratalanta
    Jan 20, 2024
  4. rvallee

    Microglia Transcriptional Profiling in Major Depressive Disorder Shows Inhibition of Cortical Gray Matter Microglia, 2023, Huitinga et al

    rvallee, Jul 23, 2023
    Replies:
    2
    Views:
    671
    ME/CFS Skeptic
    Jan 19, 2024
  5. Milo

    Knowledge on cause, clinical manifestation and treatment for fibromyalgia among medical doctors: A worldwide survey (2023) VanWilgen et al

    Milo, Jan 10, 2024
    Replies:
    0
    Views:
    485
    Milo
    Jan 10, 2024
  6. EndME

    Expanded T lymphocytes in the cerebrospinal fluid of multiple sclerosis patients are specific for Epstein-Barr-virus-infected B cells, 2024, Gottlieb+

    EndME, Jan 8, 2024
    Replies:
    0
    Views:
    591
    EndME
    Jan 8, 2024
  7. EndME

    Preprint Persistence of an infectious form of SARS-CoV-2 post protease inhibitor treatment of permissive cells in vitro, 2023, Nair et al

    EndME, Dec 28, 2023
    Replies:
    0
    Views:
    453
    EndME
    Dec 28, 2023
  8. Andy

    Social support in low-income women with [FM] from ... Tenerife (Canary Islands, Spain) 2023 Martín Pérez et al

    Andy, Dec 23, 2023
    Replies:
    0
    Views:
    533
    Andy
    Dec 23, 2023
  9. Andy

    Management perspectives from patients with fibromyalgia experiences with the healthcare pathway: a qualitative study 2023 Kachaner et al

    Andy, Dec 19, 2023
    Replies:
    0
    Views:
    638
    Andy
    Dec 19, 2023
  10. EndME

    Risk of Multiple Sclerosis in People Living with HIV: An International Cohort Study, 2023, McKAy et al

    EndME, Dec 16, 2023
    Replies:
    1
    Views:
    786
    Hutan
    Dec 17, 2023
  11. Midnattsol

    Hypothesis Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis, 2023, Vietzen et al.

    Midnattsol, Oct 17, 2023
    Replies:
    6
    Views:
    1,421
    Jonathan Edwards
    Dec 13, 2023
  12. EndME

    FTY720 requires vitamin B12-TCN2-CD320 signaling in astrocytes to reduce disease in an animal model of multiple sclerosis, 2023, Kihara et al

    EndME, Dec 12, 2023
    Replies:
    0
    Views:
    491
    EndME
    Dec 12, 2023
  13. Andy

    Efficient assessment of brain fog and fatigue: Development of the Fatigue and Altered Cognition Scale (FACs) 2023 Elliott et al

    Andy, Dec 12, 2023
    Replies:
    0
    Views:
    742
    Andy
    Dec 12, 2023
  14. Andy

    The lower Saint Lawrence River region of Quebec, a hot spot for sheepfold-associated Q fever in Canada: Review of 258 cases, 2023, Dolcé et al

    Andy, Dec 9, 2023
    Replies:
    0
    Views:
    577
    Andy
    Dec 9, 2023
  15. Andy

    Depression is the most significant independent predictor of fatigue in patients with primary Sjögren’s syndrome 2023 Ayar et al

    Andy, Dec 6, 2023
    Replies:
    10
    Views:
    925
    Sean
    Dec 9, 2023
  16. Kalliope

    Improvement in chronic pelvic pain, orthostatic intolerance and interstitial cystitis symptoms after treatment of pelvic vein insufficiency, 2023

    Kalliope, Dec 6, 2023
    Replies:
    0
    Views:
    695
    Kalliope
    Dec 6, 2023
  17. Andy

    Treatment and life goals among veterans with Gulf War illness 2023 Sullivan et al

    Andy, Dec 1, 2023
    Replies:
    3
    Views:
    838
    Sean
    Dec 3, 2023
  18. EndME

    Chikungunya-virus-specific CD4+ T cells are associated with chronic chikungunya viral arthritic disease in humans, 2023, Chang et al

    EndME, Nov 22, 2023
    Replies:
    0
    Views:
    547
    EndME
    Nov 22, 2023
  19. EndME

    Dazodalibep (VIB4920/HZN4920) in Sjögren’s Subjects with an Unacceptable Symptom Burden: Safety and Efficacy from a Phase 2, Randomized, Double-Blind

    EndME, Nov 19, 2023
    Replies:
    2
    Views:
    922
    Jonathan Edwards
    Nov 20, 2023
  20. Andy

    Validation of symptom measures in patients under investigation for postural orthostatic tachycardia syndrome (POTS):... 2023 Iris Knoop, Moss-Morris

    Andy, Nov 19, 2023
    Replies:
    3
    Views:
    687
    Trish
    Nov 19, 2023
Showing threads 221 to 240 of 899

Thread Display Options

Loading...
Page 12 of 45